Cat litter is a possible trigger for sarcoidosis

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 221-222

  Drent, M ^a   Wijnen, P A ^a   Boots, A W ^b   Bast, A ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; FOLIC ACID; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; PREDNISONE; SILICON DIOXIDE;

ADULT; CASE REPORT; CAT LITTER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTAINER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LETTER; LUNG DIFFUSION CAPACITY; LUNG LAVAGE; LUNG SARCOIDOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANIMALS; CATS; ENVIRONMENTAL EXPOSURE; FECES; FEMALE; HUMANS; INFLAMMATION; PULMONARY MEDICINE; SARCOIDOSIS; SILICON DIOXIDE; URINE;

EID: 84855382251     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00074411     Document Type: Letter

References (12)

1. Culver DA, Newman LS, Kavuru MS. Gene - environment interactions in sarcoidosis: challenge and opportunity. Clin Dermatol 2007; 25: 267-275. (Pubitemid 46856828)
2. Drent M, Bomans PH, Van Suylen RJ, et al. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 2000; 94: 815-820. (Pubitemid 30628244)
3. Rafnsson V, Ingimarsson O, Hjalmarsson I, et al. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 1998; 55: 657-660. (Pubitemid 28428962)
4. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
5. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852. (Pubitemid 36019637)
6. Solà R, Boj M, Hernandez-Flix S, et al. Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet 2009; 373: 1943-1944.
7. Calvert GM, Rice FL, Boiano JM, et al. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60: 122-129. (Pubitemid 36157372)
8. Drent M, Jacobs JA, Cobben NA, et al. Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release. Respir Med 2001; 95: 781-786. (Pubitemid 33019571)
9. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 143-149.
10. Koutsokera A, Papaioannou AI, Malli F, et al. Systemic oxidative stress in patients with pulmonary sarcoidosis. Pulm Pharmacol Ther 2009; 22: 603-607.
11. Drent M, van den Berg R, Haenen GR, et al. NF-κB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 50-56.
12. Iqbal A, Aggarwal B, Menon B, et al. Talc granulomatosis mimicking sarcoidosis. Singapore Med J 2008; 49: e168-e170.